Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME program

PURPOSE: Among metastatic breast cancer (MBC) patients, those with a triple-negative breast cancer phenotype (mTNBC) have the worst prognosis, but the benefit of chemotherapy beyond second line on outcome remains uncertain. The purpose of this study was to identify predictive factors of outcome afte...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Breast
Main Authors: Cabel, Luc, Carton, Matthieu, Pistilli, Barbara, Dalenc, Florence, Vanlemnens, Laurence, Levy, Christelle, Jacot, William, Debled, Michel, Loeb, Agnes, Hennequin, Audrey, De la Motte Rouge, Thibault, Laborde, Lilian, Laurent, Carine, Chamorey, E., Parent, Damien, Petit, Thierry, Mouret-Reynier, Marie-Ange, Campone, Mario, Perrocheau, Geneviève, Labreveux, Claire, Bachelot, Thomas, Robain, Mathieu, Lerebours, Florence
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2021
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7873471/
https://ncbi.nlm.nih.gov/pubmed/33561617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2021.01.006
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki